GW Pharmaceuticals PLC
GWPH
Depository Receipt
$218.96
Sector: Health Care
Industry: Pharmaceuticals
Sub-Industry: Pharmaceuticals
Exposures: Marijuana
|
|
|
| 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|
| (Diluted) Earnings Per Share | -$1.87 | -$0.29 | -$9.61 | -$6.69 | -$3.99 |
| Sales/Revenue | $531.31 M | $312.62 M | $15.49 M | $10.58 M | $14.58 M |
| Sales Growth | 69.95% | 1918.66% | 46.35% | -27.44% | 0.00% |
| Gross Margin | +92.88 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -$58.58 M | -$9.06 M | -$272.69 M | -$169.15 M | -$90.00 M |
| Net Income Growth | -546.84% | 96.68% | -61.21% | -87.93% | 0.00% |
| Net Margin | -11.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -$40.08 M | -$113.65 M | -$264.77 M | -$182.76 M | -$153.39 M |
| Cost of Goods Sold (incl D&A) | $37.82 M | $27.31 M | $11.01 M | $11.64 M | $9.03 M |
| Cost of Goods Sold (excl D&A) | $24.97 M | $18.03 M | $1.63 M | $4.55 M | $3.84 M |
| Cost of Goods Growth | 38.49% | 148.09% | -5.44% | 28.94% | 0.00% |
| Research & Development | $207.76 M | $147.28 M | $133.49 M | $142.87 M | $141.13 M |
| Other SG&A Expenses | $338.66 M | $260.96 M | $145.14 M | $45.93 M | $23.01 M |
| Interest Expense | $1.13 M | $1.09 M | $1.26 M | $0.96 M | $0.24 M |
| Income Tax | $2.34 M | -$4.19 M | $4.07 M | -$26.61 M | -$31.83 M |
| 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|
| (Diluted) Earnings Per Share | -$0.94 | -$0.40 | -$0.28 | -$0.26 |
| Sales/Revenue | $149.48 M | $139.51 M | $121.59 M | $120.71 M |
| Sales Growth | 7.15% | 14.73% | 0.73% | 9.18% |
| Gross Margin | +92.88 | 0.00 | 0.00 | 0.00 |
| Net Income | -$29.40 M | -$12.41 M | -$8.85 M | -$7.97 M |
| Net Income Growth | -136.93% | -40.19% | -11.04% | 68.48% |
| Net Margin | -11.03 | 0.00 | 0.00 | 0.00 |
| EBITDA | -$17.16 M | -$10.33 M | -$7.30 M | -$5.36 M |
| Cost of Goods Sold (incl D&A) | $10.51 M | $7.77 M | $8.73 M | $10.78 M |
| Cost of Goods Sold (excl D&A) | $6.86 M | $4.08 M | $5.86 M | $8.12 M |
| Cost of Goods Growth | 35.20% | -10.97% | -18.99% | 45.68% |
| Research & Development | $55.13 M | $59.03 M | $46.95 M | $46.72 M |
| Other SG&A Expenses | $104.64 M | $86.73 M | $76.08 M | $71.23 M |
| Interest Expense | $0.27 M | $0.27 M | $0.30 M | $0.28 M |
| Income Tax | $4.83 M | -$3.51 M | $0.03 M | $0.92 M |
| 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|
| Net Property and Plant Equipment | $168.89 M | $152.68 M | $89.43 M | $58.33 M | $50.59 M |
| Cash and Short-Term Investment | $486.75 M | $536.93 M | $591.50 M | $322.15 M | $486.34 M |
| Cash and Short-Term Investment Growth | -9.35% | -9.22% | 83.61% | -33.76% | 0.00% |
| Long Term Debt | $27.58 M | $27.22 M | $15.12 M | $16.98 M | $18.68 M |
| Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
| Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
| Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
| Total Assets | $939.51 M | $882.25 M | $773.95 M | $444.70 M | $588.68 M |
| Total Assets Growth | 6.49% | 13.99% | 74.04% | -24.46% | 0.00% |
| Inventories | $129.14 M | $85.53 M | $51.01 M | $5.67 M | $5.52 M |
| Finished Goods | $13.79 M | $5.01 M | $8.37 M | $0.89 M | $1.00 M |
| Short Term Debt | $6.55 M | $6.21 M | $0.94 M | $0.79 M | $1.37 M |
| Total Liabilities | $198.42 M | $156.22 M | $82.00 M | $73.12 M | $71.04 M |
| 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|
| Net Property and Plant Equipment | $168.89 M | $153.50 M | $147.44 M | $146.08 M | $152.68 M |
| Cash and Short-Term Investment | $486.75 M | $480.33 M | $477.56 M | $500.94 M | $536.93 M |
| Cash and Short-Term Investment Growth | 1.34% | 0.58% | -4.67% | -6.70% | 0.00% |
| Long Term Debt | $27.58 M | $24.83 M | $24.73 M | $25.19 M | $27.22 M |
| Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
| Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
| Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
| Total Assets | $939.51 M | $910.26 M | $870.58 M | $854.38 M | $882.25 M |
| Total Assets Growth | 3.21% | 4.56% | 1.90% | -3.16% | 0.00% |
| Inventories | $129.14 M | $115.04 M | $99.62 M | $89.06 M | $85.53 M |
| Finished Goods | $13.79 M | $9.78 M | $10.06 M | $5.62 M | $5.01 M |
| Short Term Debt | $6.55 M | $6.02 M | $5.87 M | $6.08 M | $6.21 M |
| Total Liabilities | $198.42 M | $175.81 M | $153.64 M | $139.37 M | $156.22 M |
| Expiration Date | Call To Put Ratio | Open Money on Chain |
|---|
| Quarter | Amount | Yield |
|---|
|
|